TRPV2 and prostate carcinoma: Similarly, TRPV2 mRNA expression was found to be ≈12 times higher in aggressive late stage metastatic human prostate cancer samples than in localized specimens, and TRPV2 silencing reduced prostate tumor development in a xenograft mouse model20.